THROMBATE III (antithrombin iii- human kit THROMBATE III (antithrombin iii- human kit United States - English - NLM (National Library of Medicine)

thrombate iii (antithrombin iii- human kit thrombate iii (antithrombin iii- human kit

grifols usa, llc - antithrombin iii human (unii: t0lto7l82x) (antithrombin iii human - unii:t0lto7l82x) - antithrombin iii human 50 [iu] in 1 ml - thrombate iii is a human antithrombin (at) indicated in patients with hereditary antithrombin deficiency for: - treatment and prevention of thromboembolism - prevention of peri-operative and peri-partum thromboembolism none. risk summary there are no data with thrombate iii use in pregnant women to inform a drug-associated risk. however, there are clinical considerations [see clinical considerations] . it is not known whether thrombate iii can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. thrombate iii should be given to a pregnant woman only if clearly needed. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. reproduction studies have been performed in rats and rabbits at doses up to four times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to thrombate iii. clinical considerations labor or delivery suspend heparin (or low molecular weight heparin) administration and continue thrombate iii administration during labor and delivery. risk summary there is no information regarding the presence of thrombate iii in human milk, the effects on the breastfed infant, or the effects on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for thrombate iii and any potential adverse effects on the breastfed infant from thrombate iii or from the underlying maternal condition. safety and effectiveness in the pediatric population have not been established. the safety and effectiveness in the geriatric population have not been established.

Antithrombin III Baxalta 50 IU/ml, powder and solvent for solution for injection or infusion - 20ml Malta - English - Medicines Authority

antithrombin iii baxalta 50 iu/ml, powder and solvent for solution for injection or infusion - 20ml

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - antithrombin iii - powder and solvent for solution for infusion or injection - antithrombin iii 50 iu - antithrombotic agents

Antithrombin III Baxalta 50 I.U./ml, powder and solvent for solution for injection or infusion -10ml Malta - English - Medicines Authority

antithrombin iii baxalta 50 i.u./ml, powder and solvent for solution for injection or infusion -10ml

baxalta innovations gmbh industriestrasse 67, 1221, vienna, austria - antithrombin iii - powder and solvent for solution for infusion or injection - antithrombin iii 50 iu/ml - antithrombotic agents

ANTITHROMBIN III NF KIT Canada - English - Health Canada

antithrombin iii nf kit

takeda canada inc - antithrombin iii (human) - kit - 1100unit - antithrombin iii (human) 1100unit - direct thrombin inhibitors

ANTITHROMBIN III NF KIT Canada - English - Health Canada

antithrombin iii nf kit

takeda canada inc - antithrombin iii (human) - kit - 550unit - antithrombin iii (human) 550unit - direct thrombin inhibitors

ANTITHROMBIN III IMMUNO POWDER FOR SOLUTION Canada - English - Health Canada

antithrombin iii immuno powder for solution

baxter ag - antithrombin iii (human); water - powder for solution - 1650unit; 30ml - antithrombin iii (human) 1650unit; water 30ml - direct thrombin inhibitors

Antithrombin III Baxter 50 I.U./ml, powder and solvent for solution for injection or infusion Malta - English - Medicines Authority

antithrombin iii baxter 50 i.u./ml, powder and solvent for solution for injection or infusion

baxter healthcare limited - antithrombin iii 50 iu/ml - powder and solvent for solution for infusion or injection

Concentré d'Antithrombine III Baxalta 500 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

concentré d'antithrombine iii baxalta 500 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

baxalta innovations gmbh - human antithrombin iii 500 iu/10 ml - powder and solvent for solution for injection/infusion - 500 iu - antithrombin iii 50 iu/ml - antithrombin iii

Concentré d'Antithrombine III Baxalta 1000 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

concentré d'antithrombine iii baxalta 1000 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

baxalta innovations gmbh - human antithrombin iii 1000 iu/20 ml - powder and solvent for solution for injection/infusion - 1000 iu - antithrombin iii 50 iu/ml - antithrombin iii

Antithrombin III Imuno 500 I.U. Namibia - English - Namibia Medicines Regulatory Council

antithrombin iii imuno 500 i.u.

adcock ingram critical care (pty) ltd - antithrombin iii concentrate - injection - antithrombin iii concentrate lyophilized powder in glass vials with solvent 50 iu/ml